Emerging Trends Redefining the Neonatal Phototherapy Market Landscape: Advancements In Non-Invasive Respiratory Treatments For Neonates With Hypoxic Respiratory Failure
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What is the Projected CAGR for the Neonatal Respiratory Distress Syndrome Treatment Market Size from 2025 to 2034?
In recent years, the market size for neonatal respiratory distress syndrome treatment has seen robust growth. The money generated by this market is forecasted to rise from $0.96 billion in 2024 to $1.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. Factors contributing to the growth in the historic period include an increase in permeability and fluid buildup within the alveoli, heightened alveolar-capillary permeability, a surge in the use of mechanical ventilation, more awareness amongst healthcare professionals and parents on neonatal care’s significance, as well as an uptick in healthcare investments.
Growth in the neonatal respiratory distress syndrome treatment market is anticipated to be robust in the coming years, with estimations suggesting a value of $1.41 billion by 2029, representing a compound annual growth rate (CAGR) of 8.0%. This upward trajectory during the forecast period is largely due to factors such as the increasing inclination towards accessories and consumables, a surge in NICU admissions, a growing demand of personalized medicine, an increase in premature birth occurrences, and a rise in research and development initiatives. Some key trends expected during the forecast period include the automation of neonatal intensive care units (NICUs), the incorporation of artificial intelligence (AI), progresses in neonatal care technology, innovative surfactant therapies, and advanced ventilator technologies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp
What Are the Core Market Drivers Propelling Growth in the Neonatal Respiratory Distress Syndrome Treatment Industry?
The escalating rates of premature births is projected to boost the growth trajectory of the neonatal respiratory distress syndrome treatment market. A preterm birth, also known as premature birth, is when a baby arrives before the 37th week of pregnancy. Those born prior to the 32nd week face significant health threats – a typical pregnancy is approximately 40 weeks. Factors such as increasing maternal age, multiple pregnancies, health issues, lifestyle decisions, fertility treatment usage, infections, and environmental factors contribute to the upsurge in premature births. The need for Neonatal Respiratory Distress Syndrome (NRDS) treatment is frequent among premature newborns because their lungs are immature and there is inadequate surfactant production. This therapy aids in lung function improvement, breathing stabilization, and the reduction of premature infants’ risk of respiratory failure. For example, Tommy’s, a UK-based charity organization, reported in December 2022 that the percentage of live premature births in England and Wales spiked to 7.9% in 2022 from 7.5% in 2021, demonstrating a sequential rise in premature birth incidence. Over 53,000 babies were prematurely born in 2022, highlighting the reason behind the meandering trajectory of the neonatal respiratory distress syndrome treatment market.
How Is the Neonatal Respiratory Distress Syndrome Treatment Market Segmented?
The neonatal respiratory distress syndrome treatment market covered in this report is segmented –
1) By Therapy: Oxygen Therapy, Surfactant Therapy
2) By Route Of Administration: Parenteral, Inhalation, Other Routes Of Administration
3) By End User: Hospitals, Sub-Acute Facilities, Home Care, Retail Pharmacies
Subsegments:
1) By Oxygen Therapy: Conventional Oxygen Therapy, High-Flow Nasal Cannula (HFNC) Oxygen Therapy, Continuous Positive Airway Pressure (CPAP) Oxygen Therapy, Invasive Mechanical Ventilation With Oxygen Therapy
2) By Surfactant Therapy: Natural Surfactants, Synthetic Surfactants, Combined Surfactant Therapy (Natural + Synthetic), Prophylactic Surfactant Therapy, Rescue Surfactant Therapy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20899&type=smp
Which Regions Are Driving the Next Phase of the Neonatal Respiratory Distress Syndrome Treatment Market Growth?
North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive the Neonatal Respiratory Distress Syndrome Treatment Market’s Growth?
Leading firms in the neonatal respiratory distress syndrome treatment market are focusing on the advancement of technologies such as nitric oxide generators. These aim to improve oxygenation, reduce respiratory issues, and provide non-invasive treatment methods for neonates suffering from hypoxic respiratory failure. A nitric oxide generator is a medical apparatus that produces and dispenses nitric oxide gas, which is usually used to address respiratory problems by enhancing oxygen levels and reducing pulmonary hypertension chiefly in neonates and intensely sick patients. In a recent development, Beyond Air Inc., a US-based medical device and biopharmaceutical organization, secured FDA approval for LungFit PH in June 2022. This ground-breaking nitric oxide generator is intended to treat term and near-term neonates who have hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN). The device uses Beyond Air’s proprietary Ionizer technology to create nitric oxide from ambient air on demand, supplying an unrestricted source without any worries over dosage or flow. The technology empowers a low-power compressor to ionize nitrogen and oxygen, thereby reducing nitrogen dioxide (NO2) production which is then securely removed via a smart filter.
View the full report here:
How Is the Neonatal Respiratory Distress Syndrome Treatment Market Defined and What Are Its Core Parameters?
Neonatal respiratory distress syndrome treatment refers to the management of premature infants with insufficient surfactant production, leading to breathing difficulties. It involves administering exogenous surfactant therapy, providing respiratory support with mechanical ventilation or continuous positive airway pressure (CPAP), and oxygen supplementation.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20899
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
